Cost-effectiveness analysis of the use of digoxin immune Fab(ovine) for treatment of digoxin toxicity
Authors:
- Josephine A. MauskopfJMJosephine A. Mauskopf
- Thomas L. WengerTWThomas L. Wenger
- 1 December 1991
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 68 (17) , 1709-1714
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Experience with digoxin immune Fab (ovine) in patients with renal impairmentThe American Journal of Emergency Medicine, 1991
- Digoxin Immune Fab therapy in the management of digitalis intoxication: Safety and efficacy results of an observational surveillance studyJACC, 1991
- Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study.Circulation, 1990
- Cost-effectiveness perspectives in coronary heart diseaseAmerican Heart Journal, 1990
- 1986 Annual report of the American Association of Poison Control Centers National Data Collection SystemThe American Journal of Emergency Medicine, 1987
- Digitalis IntoxicationClinical Science, 1983
- Acute, Massive Poisoning with Digitoxin: Report of Seven Cases and Discussion of TreatmentClinical Toxicology, 1981
- DigitalisNew England Journal of Medicine, 1973
- Digitalis intoxicationPostgraduate Medical Journal, 1972
- A mathematical analysis of digitalis kinetics in patients with normal and reduced renal functionMathematical Biosciences, 1967